These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 294931)

  • 1. Dihydroergotamine therapy in symptomatic postural hypotension.
    Bajada S
    Aust N Z J Med; 1979 Dec; 9(6):709-12. PubMed ID: 294931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Action of dihydroergotamine in severe orthostatic hypotension. 16 cases].
    Saïd G
    Presse Med; 1987 May; 16(17):800-3. PubMed ID: 2954090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of clonidine and dihydroergotamine on venomotor tone and orthostatic tolerance in patients with severe hypoadrenergic orthostatic hypotension.
    Victor RG; Talman WT
    Am J Med; 2002 Apr; 112(5):361-8. PubMed ID: 11904110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of orthostatic hypotension with dihydroergotamine and caffeine.
    Hoeldtke RD; Cavanaugh ST; Hughes JD; Polansky M
    Ann Intern Med; 1986 Aug; 105(2):168-73. PubMed ID: 3729199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroergotamine: an effective treatment for postural hypotension due to antihypertensive drugs (ganglion-blocking agents excepted).
    Conté JJ; Fournié GJ; Maurette MH
    Cardiology; 1976; 61 suppl 1():342-9. PubMed ID: 135643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroergotamine and mobilization after major orthopedic surgery.
    Duus BR; Hølmich P; Larsen CT; Wille-Jørgensen P; Bjerg-Nielsen A; Christensen S
    Clin Pharmacol Ther; 1986 Mar; 39(3):342-4. PubMed ID: 3948474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary electrolyte excretion and orthostatic response of blood pressure and plasma renin activity in children with postural hypotension before and after treatment with Dihydergot.
    Uchiyama M; Sakai K
    J Int Med Res; 1985; 13(1):54-8. PubMed ID: 3884412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroergotamine in idiopathic orthostatic hypotension: short-term intramuscular and long-term oral therapy.
    Fouad FM; Tarazi RC; Bravo EL
    Clin Pharmacol Ther; 1981 Dec; 30(6):782-9. PubMed ID: 7030580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dihydroergotamine on venous distensibility and blood pressure in idiopathic orthostatic hypotension.
    Bellamy GR; Hunyor SN
    Aust N Z J Med; 1984 Apr; 14(2):157-9. PubMed ID: 6591908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postural hypotension and its management.
    Hawkins S; Prout BJ
    Practitioner; 1982 Mar; 226(1365):420-2, 424, 426. PubMed ID: 7045842
    [No Abstract]   [Full Text] [Related]  

  • 11. Age-related changes in autonomic function: relationship with postural hypotension.
    Smith SA; Fasler JJ
    Age Ageing; 1983 Aug; 12(3):206-10. PubMed ID: 6624605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of orthostatic hypotension in symptomatic elderly.
    Ward C; Kenny RA
    Am J Med; 1996 Apr; 100(4):418-22. PubMed ID: 8610728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of orthostatic hypotension: interaction of pressor drugs and tilt table conditioning.
    Hoeldtke RD; Cavanaugh ST; Hughes JD
    Arch Phys Med Rehabil; 1988 Oct; 69(10):895-8. PubMed ID: 3178458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory effects of dihydroergotamine in patients with disturbed sympathetic vasomotor control with special reference to postural hypotension.
    Bevegård S; Castenfors J; Lindblad LE
    Cardiology; 1976; 61 suppl 1():322-32. PubMed ID: 975147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroergotamine therapy in orthostatic hypotension due to psychotropic drugs.
    Thulesius O; Berlin E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):465-7. PubMed ID: 2877953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of orthostatic hypotension with octreotide.
    Hoeldtke RD; Israel BC
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1051-9. PubMed ID: 2723026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic orthostatic hypotension].
    Uchida K; Himei H
    Nihon Rinsho; 1991 Feb; 49 Suppl():313-5. PubMed ID: 2033821
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo pharmacodynamic interactions between two drugs used in orthostatic hypotension--midodrine and dihydroergotamine.
    Jourdan G; Verwaerde P; Pathak A; Tran MA; Montastruc JL; Senard JM
    Fundam Clin Pharmacol; 2007 Feb; 21(1):45-53. PubMed ID: 17227444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of dihydroergotamine in patients with postural hypotension.
    Bevegård S; Castenfors J; Lindblad LE
    Acta Med Scand; 1974 Dec; 196(6):473-7. PubMed ID: 4456977
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamic effects of dihydroergotamine in orthostatic hypotension.
    Nordenfelt I; Mellander S
    Cardiology; 1976; 61 suppl 1():316-21. PubMed ID: 975146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.